Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,106 | -29,815 | -18,496 | -23,365 | -18,849 |
| Depreciation Amortization | 1,479 | 1,128 | 1,321 | 1,504 | 1,115 |
| Accounts receivable | 2,087 | -2,375 | -900 | -1,768 | -856 |
| Accounts payable and accrued liabilities | -1,810 | 1,362 | -954 | 1,542 | -609 |
| Other Working Capital | -3,440 | -4,972 | -2,369 | 85 | -2,961 |
| Other Operating Activity | 4,476 | 5,142 | 1,455 | 1,185 | -1,337 |
| Operating Cash Flow | $-38,314 | $-29,530 | $-19,944 | $-20,818 | $-23,496 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -61 | -332 | -1,018 | -1,350 |
| Net Acquisitions | -2,450 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-2,450 | $-61 | $-332 | $-1,018 | $-1,350 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 761 | 5,113 | N/A | N/A | N/A |
| Debt Issued | 1,774 | 19,134 | 23,831 | N/A | 6,887 |
| Debt Repayment | -5,000 | -10,812 | -7,448 | N/A | -5,000 |
| Common Stock Issued | 68,625 | 20,559 | 19,394 | 14 | 2 |
| Other Financing Activity | -4,258 | -3,615 | 0 | 17,594 | 23,543 |
| Financing Cash Flow | $61,902 | $30,379 | $35,776 | $17,608 | $25,431 |
| Beginning Cash Position | 17,311 | 16,523 | 1,022 | 5,250 | 4,665 |
| End Cash Position | 38,449 | 17,311 | 16,523 | 1,022 | 5,250 |
| Net Cash Flow | $21,138 | $789 | $15,501 | $-4,228 | $585 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,314 | -29,530 | -19,944 | -20,818 | -23,496 |
| Capital Expenditure | N/A | -61 | -332 | -1,018 | -1,350 |
| Free Cash Flow | -38,314 | -29,591 | -20,276 | -21,836 | -24,846 |